Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factors

  1. Dimopoulos, M.A.
  2. Sonneveld, P.
  3. Siegel, D.
  4. Palumbo, A.
  5. San-Miguel, J.
Journal:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Year of publication: 2015

Volume: 26

Issue: 11

Pages: 2247-2256

Type: Article

DOI: 10.1093/ANNONC/MDV325 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus